Literature DB >> 10323871

Towards immunotherapy of pancreatic cancer.

I F McKenzie1, V Apostolopoulos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10323871      PMCID: PMC1727555          DOI: 10.1136/gut.44.6.767

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  31 in total

Review 1.  Antigen recognition by class I-restricted T lymphocytes.

Authors:  A Townsend; H Bodmer
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 2.  The biochemistry and cell biology of antigen processing and presentation.

Authors:  R N Germain; D H Margulies
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

Review 3.  MHC ligands and peptide motifs: first listing.

Authors:  H G Rammensee; T Friede; S Stevanoviíc
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

4.  Overexpression of HER2/neu oncogene in human pancreatic carcinoma.

Authors:  Y Yamanaka; H Friess; M S Kobrin; M Büchler; J Kunz; H G Beger; M Korc
Journal:  Hum Pathol       Date:  1993-10       Impact factor: 3.466

5.  Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA.

Authors:  K R Jerome; N Domenech; O J Finn
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

6.  A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats.

Authors:  S Gendler; J Taylor-Papadimitriou; T Duhig; J Rothbard; J Burchell
Journal:  J Biol Chem       Date:  1988-09-15       Impact factor: 5.157

7.  Immunohistochemical localisation of the c-fos oncoprotein in pancreatic cancers.

Authors:  C S Lee; D Charalambous
Journal:  Zentralbl Pathol       Date:  1994-08

Review 8.  Serological pancreatic tumor markers and the MUC1 apomucin.

Authors:  J J Ho; Y S Kim
Journal:  Pancreas       Date:  1994-11       Impact factor: 3.327

9.  Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.

Authors:  P A Pasanen; M Eskelinen; K Partanen; P Pikkarainen; I Penttila
Journal:  Anticancer Res       Date:  1993 Sep-Oct       Impact factor: 2.480

10.  K-ras mutations in stools and tissue samples from patients with malignant and nonmalignant pancreatic diseases.

Authors:  C Berndt; K Haubold; F Wenger; B Brux; J Müller; P Bendzko; T Hillebrand; E Köttgen; J Zanow
Journal:  Clin Chem       Date:  1998-10       Impact factor: 8.327

View more
  2 in total

1.  Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells.

Authors:  Kuo-Ching Sheng; Dodie S Pouniotis; Mark D Wright; Choon Kit Tang; Eliada Lazoura; Geoffrey A Pietersz; Vasso Apostolopoulos
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

2.  T cell adhesion and cytolysis of pancreatic cancer cells: a role for E-cadherin in immunotherapy?

Authors:  J J French; J Cresswell; W K Wong; K Seymour; R M Charnley; J A Kirby
Journal:  Br J Cancer       Date:  2002-10-21       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.